Grants and Contracts Details
Description
ARCADIA-CSI is an ancillary study to the ARCADIA trial that will add two outcomes (cognition
and silent infarction) to the parent trial. The purpose of ARCADIA-CSI is to determine the effect
of apixaban vs aspirin on these two additional outcomes in patients with stroke of unknown
cause and atrial cardiopathy.
Patients randomized in ARCADIA will be eligible for ARCADIA-CSI if they can undergo cognitive
testing (English speakers with score
Status | Finished |
---|---|
Effective start/end date | 7/1/19 → 1/8/24 |
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.